- Investing.com
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company offers Platinum NGPS instrument that provides single molecule amino acid level resolution with a streamlined workflow, including automated data analysis that accessible to researchers in all laboratory types; Platinum Pro NGPS instrument, a single molecule amino acid resolution, which provides an enhanced user interface, cloud or on instrument data analysis and an available pro mode; Library preparation kits to prepare protein sample for sequencing; Barcoding Kits to optimize the workflow and performance of technology; and Sequencing Kits contains the reagents and consumables used to perform NGPS on the Platinum or Platinum Pro instrument. It also provides Platinum Analysis Software, a cloud-based solution that automates data analysis workflows and provides a user-friendly interface and visualization of the sequencing results. Its products are used in antibody characterization, biomarker identification, protein identification, protein variants, protein barcoding, and post translational modification analysis applications. Quantum-Si incorporated was founded in 2013 is headquartered in Branford, Connecticut.
Metrics to compare | QSI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipQSIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.3x | −6.0x | −0.6x | |
PEG Ratio | 1.03 | −0.23 | 0.00 | |
Price/Book | 1.1x | 1.7x | 2.6x | |
Price / LTM Sales | 83.4x | 2.8x | 3.2x | |
Upside (Analyst Target) | 103.3% | 18.6% | 41.8% | |
Fair Value Upside | Unlock | 5.8% | 5.1% | Unlock |